Abbott India Limited (NSE:ABBOTINDIA)
India · Delayed Price · Currency is INR | Market Cap | 572.64B -11.1% |
| Revenue (ttm) | 70.04B +6.3% |
| Net Income | 16.15B +11.2% |
| EPS | 759.88 +11.2% |
| Shares Out | n/a |
| PE Ratio | 35.46 |
| Forward PE | 32.46 |
| Dividend | 656.00 (2.44%) |
| Ex-Dividend Date | Jul 24, 2026 |
| Volume | 4,548 |
| Open | 27,225 |
| Previous Close | 27,225 |
| Day's Range | 26,905 - 27,490 |
| 52-Week Range | 25,135 - 30,655 |
| Beta | 0.04 |
| Analysts | Buy |
| Price Target | 32,206.13 (+19.68%) |
| Est. Earnings | Nov 6, 2026 |
About Abbott India
Abbott India Limited, together with its subsidiaries, operates as a pharmaceutical company in India. The company offers pharmaceutical products for gastroenterology, women’s health, metabolic, hypothyroidism, central nervous system, vaccines, and multispecialty, including insomnia, vertigo, vitamin D deficiency, pre-term labor, and pain management. It also provides anti-infectives, cardio-diabeto, GI & hepato, hormones, neuro-psychiat, respiratory, hepatic, neuroscience, metabolics, gennext, and consumer care products. The company was formerly ... [Read more]
Financial Performance
In fiscal year 2026, Abbott India's revenue was 69.29 billion, an increase of 8.11% compared to the previous year's 64.09 billion. Earnings were 15.52 billion, an increase of 9.73%.
Financial StatementsAnalyst Summary
According to 8 analysts, the average rating for ABBOTINDIA stock is "Buy." The 12-month stock price target is ₹32,206, which is an increase of 19.68% from the latest price.
News
Abbott India Quarterly report: Q1 2027
Abbott India has published its Q1 2027 quarterly earnings report on August 11, 2026.
Abbott India Quarterly report: Q4 2026
Abbott India has published its Q4 2026 quarterly earnings report on May 10, 2026.
Abbott India Annual report: Q4 2026
Abbott India has published its Q4 2026 annual report on May 10, 2026.
Pharma sector stocks today, March 12: Divi's Laboratories down 1.87%, Abbott India drops 1.51%, Aarti Drugs falls 1.36%
The Indian pharmaceutical sector experienced a decline on March 12, 2026, with most listed stocks trading lower in early morning sessions. The S&P BSE HEALTHCARE Index stood at 43,421.7, down…
Abbott India Quarterly report: Q3 2026
Abbott India has published its Q3 2026 quarterly earnings report on February 12, 2026.
Abbott India Quarterly report: Q2 2026
Abbott India has published its Q2 2026 quarterly earnings report on November 5, 2025.
Abbott India Quarterly report: Q1 2026
Abbott India has published its Q1 2026 quarterly earnings report on August 11, 2025.
Abbott India Annual report: Q4 2025
Abbott India has published its Q4 2025 annual report on July 18, 2025.
Abbott India Quarterly report: Q4 2025
Abbott India has published its Q4 2025 quarterly earnings report on July 18, 2025.
Abbott India shares surge 3% as net profit jumps 16% YoY to Rs 360.8 crore in Q3
Abbott India’s shares surged by 3% following the company’s impressive financial results for Q3. As of 1:41 PM, the shares were trading 3.24% higher at Rs 26,970.60. The company posted a 16% year-on-ye...
Abbott India Quarterly report: Q3 2025
Abbott India has published its Q3 2025 quarterly earnings report on February 4, 2025.
Pharma stocks: Glenmark up 1.57%, Glaxo gains 1.31%, Mankind Pharma declines 2.84%
The pharmaceutical sector exhibited a mix of gains and losses in early trading. Here’s a detailed overview: Gainers: Glenmark Pharmaceuticals surged +1.57%, trading at ₹1,527.20. GlaxoSmithKline (Glax...
Pharma Stocks Today: Biocon surges 4.41%, Mankind Pharma up 1.85%; Glaxo and Abbott India decline
Pharma stocks showed mixed trends in early trading as of 9:24 AM today. Biocon led the gainers, rising 4.41% to trade at ₹381.30, while Mankind Pharma climbed 1.85%, trading at ₹2,644.05. Top Gainers:...
Stock Market Update, January 7: Apollo Hospitals, Apar Industries, Abbott India, Amber Enterprises and more hit 52-week highs today
The Indian stock market performed well on January 7, 2025, with the Nifty and Sensex indices closing on a positive note. The Nifty index rose by 91.85 points, or 0.39%, while the Sensex increased by 2...
Pharma Stocks: Cipla down nearly 2%, Ajanta Pharma down 1.45%, Abbott India up 1.27%
The Nifty Pharma index was trading 0.25% lower at 22,389.10 during today’s session, as losses in Cipla, Biocon, and Aurobindo Pharma weighed on the sector, despite gains in Abbott India and Ajanta Pha...
Abbott India launches 14-Valent Pneumococcal Conjugate vaccine offering broad protection for children
The PneumoShield 14 vaccine protects against 14 different strains of pneumococcal bacteria, exceeding the coverage of PCV-10 and PCV-13 vaccines currently available in India.
Abbott India shares fall nearly 4% following Q2 results
Abbott India reported its financial performance for the second quarter of FY25, showcasing solid growth in both revenue and net profit compared to the same period last year. However, the positive resu...
Abbott India Q2 FY25 Results: Revenue up 9.3% YoY to ₹1,632.67 crore, Net Profit rises 14.6% YoY
Abbott India Ltd. reported its financial results for the second quarter of FY25, showing strong growth in both revenue and net profit compared to the same period last year. Financial Highlights Revenu...
Abbott India Quarterly report: Q2 2025
Abbott India has published its Q2 2025 quarterly earnings report on November 6, 2024.
Pharma stocks today: Gland Pharma rises 1.53%, Aurobindo Pharma up 1.38%, while Natco Pharma falls 1.40%, and Laurus Labs down 1.41%
As of 10:31 AM, the pharma sector has witnessed both gains and losses. Gland Pharma is the top gainer, rising by 1.53% to ₹1,675.40, followed by Aurobindo Pharma, up 1.38% at ₹1,493.00. Mankind Pharma...
Pharma Stocks Update: Check out how Cipla, Lupin, Abbott India, Divi’s Lab, Zydus Life, Dr Reddy’s Lab are performing today
JB Chem rises 1.91%, Biocon gains 0.87%, while Natco Pharma drops 2.65% and Gland Pharma slips 1.38% in today's trade.
Abbott India partners with Takeda Pharmaceuticals to launch Vonefi
Abbott India Limited has announced the signing of a non-exclusive patent license agreement with Takeda Pharmaceuticals Company Limited to market and distribute Vonoprazan in India under the brand name...
Stocks Hitting 52-Week Highs Today: Trent, TVS Motor, Abbott India and others
Several stocks reached new 52-week highs in today’s market on August 22, showcasing strong performances across different sectors. Trent Ltd: Fashion retailer Trent Ltd touched a 52-week high at Rs 6,9...